Edition:
India

FibroGen Inc (FGEN.OQ)

FGEN.OQ on NASDAQ Stock Exchange Global Select Market

41.77USD
1:30am IST
Change (% chg)

$-0.05 (-0.12%)
Prev Close
$41.82
Open
$41.79
Day's High
$42.32
Day's Low
$41.44
Volume
119,850
Avg. Vol
332,498
52-wk High
$48.95
52-wk Low
$22.65

Select another date:

BRIEF-Fibrogen Says On July 8, Units And Astrazeneca Entered Into An Amendment To Amended And Restated License, Development And Commercialization Agreement

* FIBROGEN - ON JULY 8, UNITS AND ASTRAZENECA ENTERED INTO AN AMENDMENT TO AMENDED AND RESTATED LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT

BRIEF-FibroGen Announces First Patient Enrolled In Pamrevlumab Clinical Trial For Acute Covid-19

* FIBROGEN ANNOUNCES FIRST PATIENT ENROLLED IN PAMREVLUMAB CLINICAL TRIAL IN PATIENTS HOSPITALIZED IN U.S. WITH ACUTE COVID-19

BRIEF-Fibrogen Announces New Roxadustat Data Presented At 2020 Era-Edta Virtual Congress

* FIBROGEN ANNOUNCES NEW ROXADUSTAT DATA PRESENTED AT 2020 ERA-EDTA VIRTUAL CONGRESS

BRIEF-Fibrogen Says First Patient Enrolled In COVID-19 Trial In Italy

* FIBROGEN ANNOUNCES FIRST PATIENT ENROLLED IN PAMREVLUMAB CLINICAL TRIAL IN PATIENTS HOSPITALIZED IN ITALY WITH SEVERE COVID-19 Source text for Eikon: Further company coverage:

BRIEF-Fibrogen Says UK High Court Of Justice Has Held Certain Patents Relating To Methods Of Using HIF-PHIs To Be Invalid

* FIBROGEN - UK HIGH COURT OF JUSTICE HAS HELD CERTAIN PATENTS RELATING TO METHODS OF USING HIF-PHIS TO BE INVALID

BRIEF-Fibrogen Inc Signs Agreement For Bulk Manufacture/Supply Of Roxadustat

* FIBROGEN INC - AGREEMENT WITH SHANGHAI SYNTHEALL PHARMACEUTICAL CO LTD, STA PHARMACEUTICAL HONG KONG LIMITED FOR BULK MANUFACTURE/SUPPLY OF ROXADUSTAT

BRIEF-Fibrogen Says As Of February 11 James Schoeneck Resigned From Role Of Interim President

* FIBROGEN INC - AS OF FEBRUARY 11 JAMES SCHOENECK RESIGNED FROM ROLE OF INTERIM PRESIDENT

Select another date: